Aktis Oncology Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 17.83, 14.86, 2, 7.99, 111.06 ], "ebit_estimate": [ -98.92, -133.74, -185.82, -240.07, -223.75 ], "ebitda_estimate": [ -132, -146, null, null, null ], "net_income_estimate": [ -82.53, -113.13, -155.06, -224.7, -149.27 ], "per_share_eps_estimate": [ -1.61, -2.04, -2.75, -3.22, -3.41 ], "eps_nri_estimate": [ -1.73, -2.18, -3, -4.15, -3.18 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 2.02, 3.41, null, null, null ], "pretax_income_estimate": [ -82.88, -119.63, -173.37, -254.85, -202.27 ], "operating_cash_flow_per_share_estimate": [ -1.05, -1.23, null, null, null ], "roa_estimate": [ -23.7, -18.5, null, null, null ], "roe_estimate": [ 655.7, -60.3, null, null, null ], "gross_margin_estimate": [ 100, null, null, null, 75 ], "operating_cash_flow_estimate": [ -51.06, -59.82, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": 61.55, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 62.52, "future_eps_nri_estimate_growth": 61.55, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -35.47, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -34.75, "future_pretax_income_estimate_growth": -40.06, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ 2.08, 2.08, 10.66, 1.33, 1.33, 1.33, 1.33, 1.5 ], "ebit_estimate": [ -26.42, -28.25, -21.83, -33.98, -35.98, -38.01, -39.72, null ], "ebitda_estimate": [ null, null, null, null, null, null, null, null ], "net_income_estimate": [ -23.16, -24.79, -16.52, -26.64, -27.72, -28.83, -29.98, null ], "per_share_eps_estimate": [ -0.44, -0.47, -0.3, -0.56, -0.55, -0.59, -0.61, null ], "eps_nri_estimate": [ -0.41, -0.44, -0.31, -0.58, -0.59, -0.63, -0.65, -0.9 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -22.82, -24.51, -25.67, -30.37, -32.61, -34.86, -36.61, null ], "operating_cash_flow_per_share_estimate": [ null, 0.3, -1.31, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ 100, 100, 100, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, 14.59, -63.71, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null, null ], "long_term_growth_rate_mean": 61.55, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 62.52, "future_eps_nri_estimate_growth": 61.55, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -35.47, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -34.75, "future_pretax_income_estimate_growth": -40.06, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }